Tell us what you think about the new Article Page. Send us feedback
Antisoma to present at Piper Jaffray Conference
Antisoma to present at Piper Jaffray Annual Healthcare Conference in New York
- Press Release
- Source: Antisoma plc
- On Wednesday November 26, 2008, 11:54 am EST
LONDON, UK and CAMBRIDGE, MA--(MARKET WIRE)--Nov 26, 2008 -- Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Chief Executive, Glyn Edwards, will be presenting at the Piper Jaffray Healthcare Conference in New York on Wednesday, 3rd December at 10am EST/3pm GMT.
A webcast of the presentation will be available on Antisoma's website at http://www.antisoma.com/asm/media/webcast/
For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.
Enquiries: Daniel Elger Director of Communications Antisoma plc +44 7909 915 068
Background on Antisoma
Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit www.antisoma.com for further information about Antisoma.
---END OF MESSAGE---
This announcement was originally distributed by Hugin. The
issuer is solely
responsible for the content of this announcement.
Copyright © Hugin AS 2008. All rights reserved.
Contact:
Sponsored Links
-
Live Forex Practice Account
Practice Forex Trading in Real Market Conditions with a Free Trial. -
Earn From 2.35% to 2.65%
With GE Capital Corporation. Not An Offer Of Securities For Sale.
-
Buy Stocks for $4
No account or investment minimums. No inactivity fees. Start Today. -
Financing - Bank of America®
Take Advantage Of Low Refi Rates For Home Loans Up To $3 Million.
Tech Ticker Recent Posts
Add Alert Copyright © 2009 Marketwire. All rights reserved. All the news releases provided by Marketwire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.